About Hemab
Hemab is a company that creates preventative treatments for bleeding and thrombosis problems. The medicines developed by the business aggregate, modify, balance, and at times recruit endogenous clotting components already present in the blood to the site of injury, allowing patients to produce hemostatic plugs or clots to avert life-threatening complications.
Hemab Therapeutics was established in 2017 in Copenhagen, Hovedstaden by Johan H. Faber and Mads Behrndt.
Hemab is a company that creates preventative treatments for bleeding and thrombosis problems. The medicines developed by the business aggregate, modify, balance, and at times recruit endogenous clotting components already present in the blood to the site of injury, allowing patients to produce hemostatic plugs or clots to avert life-threatening complications. Hemab Therapeutics was established in 2017 in Copenhagen, Hovedstaden by Johan H. Faber and Mads Behrndt.
Company Highlights
Year Founded
2019
Employees
45
Location (HQ)
DNK
Since Last Funding
1 year 6 months
Monthly Website Visitors
2.1K
Total Investment Amt
$200M
Last Funding Round
Series B
MoM Headcount Growth
2.27%
YoY Headcount Growth
45.02%
Key Metrics
Senior Hires
Name | Linkedin Profile | Position | Date Joined |
---|---|---|---|
John Doe | https://www.linkedin.com/in/johndoe | CEO | CEO |
Jane Doe | https://www.linkedin.com/in/janedoe | CTO | CTO |
John Smith | https://www.linkedin.com/in/johnsmith | CFO | CFO |
Jane Smith | https://www.linkedin.com/in/janesmith | COO | COO |
Similar Companies
- HemoShear TherapeuticsAbyrxInnovative Trauma CareSt. Teresa MedicalHemostemixExThera MedicalApcinteXSuperXPamBioHaemostatixInspiration BiopharmaceuticalsHemotuneVarmXDraupnir BioHemispherianEntegrionHemCon Medical TechnologiesHemaCare CorporationNational Hemophilia FoundationMedicQuantGeneVentiv TherapeuticsAvana HealthHbO2 TherapeuticsPlasFreeCayuga BiotechHaima TherapeuticsAplagonRetham TechnologiesHemoalgaeJames Hambro & PartnersHHT Canada THHWorld Federation of Hemophilia / Fédération mondiale de l'hémophilieHaag-Streit USA
Pharmaceutical
Biotechnology
- Particle3DKaffe BuenoBiograilCathVisionSecondCircleSecondCircleHoba TherapeuticsBioomixGreenLabCellugyCellugyAntag TherapeuticsAntag TherapeuticsADCendoADCendoResoTher PharmaAgrobiomicsAquaGreenAcesion PharmaAlgiecelAlgiecelNeurescueOrphazymeOrphazymeFluoGuideFluoGuidePipeBioPipeBioMonta biosciencesMonta biosciencesClinical MicrobiomicsReapplixHenlezHenlezNordic Virtual PasturesCysBioCysBioNorFalkNorFalkAFYX TherapeuticsAFYX TherapeuticsCirqle Biomedical Contraception ApSCirqle Biomedical Contraception ApSChromologicsChromologicsSamplixSamplixSundewSundewSTipe TherapeuticsSTipe TherapeuticsAccelerace2cureXDraupnir BioDraupnir BioBiosyntiaBiosyntiaRSP Systems A/STeitur TrophicsTeitur TrophicsEvodiaBioEvodiaBioSNIPR BiomeSNIPR BiomeFlow RoboticsEnduro GeneticsEnduro GeneticsGalectoGalectoBeyond Leather MaterialsCommit BiologicsBioPheroExpreS2ionExpreS2ionSanionaFaunaPhotonicsPentaBaseTetra PharmLiPlasome PharmaLiPlasome PharmaFuse VectorsVesper BioREhalerBioPorto DiagnosticsOctarine BioOctarine BioSynklinoSynklinoDianoxCirqle BiomedicalCirqle BiomedicalMS-OmicsARCEDI BiotechInProTherInProTherUNION therapeutics A/SStemMedicalStemMedical
Biotechnology Research
- SecondCircleHoba TherapeuticsBioomixCellugyAntag TherapeuticsADCendoAgrobiomicsAlgiecelFluoGuidePipeBioMonta biosciencesClinical MicrobiomicsgMendelHenlezNordic Virtual PasturesCysBioNorFalkAFYX TherapeuticsCirqle Biomedical Contraception ApSAbzuChromologicsSamplixSundewSTipe TherapeuticsDraupnir BioBiosyntiaTeitur TrophicsEvodiaBioSNIPR BiomeDNA Diagnostic A/SFlow RoboticsEnduro GeneticsGalectoBeyond Leather MaterialsCommit BiologicsExpreS2ionOrbis MedicinesNucleate DenmarkPentaBaseTetra PharmLiPlasome PharmaFuse VectorsFreya BiosciencesVesper BioBioPorto DiagnosticsOctarine BioSynklinoBioNordika Denmark A/SDianoxCirqle BiomedicalMS-OmicsARCEDI BiotechViroGatesInProTherUNION therapeutics A/SStemMedical